Orthocell Ltd News

Orthocell Has Strategy Validated With A$17 Million Raised to Fund US Launch of Remplir and Drive Commercialisation

Investing.com Oct 31 09:14

Orthocell Ltd Announces AGM and Global Expansion

TipRanksOct 25 11:58

Orthocell Ltd: Annual Report to Shareholders

ASXOct 25 09:27 · Announcements

Orthocell Ltd Announces New ASX Securities Placement

TipRanksOct 25 09:11

Orthocell Secures $17 Million in Share Placement to Launch Remplir Into US Market | ASX:OCC, OTC:ORHHF

Proactive InvestorsOct 25 08:22

Petra Capital Sticks to Their Buy Rating for Orthocell Ltd (OCC)

TipRanksOct 25 07:31 · Ratings

Orthocell Price Target Raised 3.1% to A$1.32/Share by Petra Capital

Dow JonesOct 23 05:24 · Ratings

Orthocell Ltd Reports Expiry of Unexercised Options

TipRanksOct 15 12:18

Orthocell Garners Regulatory Approval for Remplir in 'Gateway' Asian Market of Singapore

Investing.com Oct 8 08:50

Orthocell Seeks Trading Halt Ahead of Announcement on Remplir Regulatory Approval

MT NewswiresOct 7 13:40

Orthocell Ltd: Second Consecutive Record Quarter as Revenue Exceeds $2m

ASXOct 7 05:56 · Announcements

Orthocell Makes First Sale of Collagen Medical Device in Canada

MT NewswiresSep 6 08:36

Orthocell Ltd Unveils Investment Opportunity

TipRanksAug 30 11:58

Orthocell Ltd: Appendix 4E & Annual Report

Aug 30 11:49 · Announcements

Orthocell Ltd Announces New Employee Share Plan

TipRanksAug 8 15:47

Orthocell Progresses Expansion Strategy With Singapore Regulatory Applications for Striate+ Submitted

Investing.com Jul 29 08:50

Orthocell Expands Global Footprint of Medical Device Products; Shares Rise 3%

MT NewswiresJul 24 12:39

Orthocell Pushes Into Global Market for Striate+ and Remplir With Regulatory Approvals Pending

Investing.com Jul 24 09:05

Orthocell Secures Market Clearance for Dental Regenerative Product in Canada; Shares Rise 4%

MT NewswiresJul 11 10:01

Orthocell's Revenue Up 9% in June Quarter; Shares Rise 4%

MT NewswiresJul 9 13:11